

Meet Dr. Mireia Camos Guijosa, an exceptional hematologist based at Sant Joan de Déu Hospital in Barcelona, Spain, with a distinguished career spanning 12 years. Dr. Camos Guijosa is widely acknowledged for her expertise in hematology oncology, particularly in the treatment of various blood disorders, with a notable focus on Leukemia. Her commitment to advancing the field extends beyond patient care as she proudly represents Spain on the Biology & Diagnosis Committee of the esteemed international I-BFM Group, showcasing her dedication to global collaboration and knowledge exchange. Dr. Camos Guijosa's academic journey commenced with her graduation from the University of Barcelona in 1995, followed by specialized residential education in hematology at the same institution in 2000. Her pursuit of knowledge reached its pinnacle in 2007 when she obtained a Ph.D. from the University of Barcelona. Since 2008, Dr. Mireia Camos Guijosa has contributed significantly to the field as an associate physician in hematology at the University of Barcelona. Her impact extends to the SJD Research Institute, where she has been instrumental in leukemia and non-malignant blood disorder research centers since 2012. Notably, since 2016, she has represented Spain at the Biology & Diagnosis Committee of the international I-BFM Group, solidifying her role as a key player in shaping advancements in hematology on a global scale. Dr. Mireia Camos Guijosa has further enriched the scientific community with her publications on both national and international levels, contributing to the ongoing progress in hematology research.
Dr. Mireia Camos Guijosa stands at the forefront of hematology oncology, specializing in the treatment of leukemia and other blood disorders. With 12 years of experience, she has developed an expertise that transcends patient care, contributing significantly to global research and scientific advancements. Dr. Camos Guijosa's work as representative of Spain on the Biology & Diagnosis Committee of the I-BFM Group underscores her commitment to international collaboration in hematology research. She has been instrumental in shaping treatment protocols and advancing diagnostic techniques through her work at the SJD Research Institute and her extensive publication record. Her dedication to the scientific community and her role as a leading hematology oncologist have earned her recognition as one of the key contributors to the field, particularly in leukemia treatment and research.